Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUM vs GSK✓SelectedUSD · GSKHUM vs GSK performance historyLatest closeAs of-1.50%11/19
Stock and ETF performance explorer

HUM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.1%
GSK return
+39.6%
Excess return
-47.7%
Maximum drawdown
-69.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%+0.1%-1.2%
7D-14.4%-4.7%-9.6%-13.6%
30D-10.9%-4.7%-6.2%-10.2%
3M+0.7%-8.8%+9.5%+2.3%
6M+22.9%-4.6%+27.5%+23.5%
YTD+49.8%+1.0%+48.8%+47.7%
1Y+68.2%+6.9%+61.3%+63.8%
3Y-20.9%+52.5%-73.4%-30.7%
5Y-8.1%+40.3%-48.4%-22.8%
All-8.1%+39.6%-47.7%-22.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling